BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10233839)

  • 1. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.
    Pinto AP; Lin MC; Mutter GL; Sun D; Villa LL; Crum CP
    Am J Pathol; 1999 Apr; 154(4):1009-15. PubMed ID: 10233839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas.
    Flowers LC; Wistuba II; Scurry J; Muller CY; Ashfaq R; Miller DS; Minna JD; Gazdar AF
    J Soc Gynecol Investig; 1999; 6(4):213-21. PubMed ID: 10486784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia.
    Lin MC; Mutter GL; Trivijisilp P; Boynton KA; Sun D; Crum CP
    Am J Pathol; 1998 May; 152(5):1313-8. PubMed ID: 9588899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic aberrations and human papillomavirus status in vulvar squamous cell carcinomas].
    Ouyang L; Zhang SL; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):701-5. PubMed ID: 17199928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.
    Rosenthal AN; Hopster D; Ryan A; Jacobs IJ
    Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva.
    Pinto AP; Lin MC; Sheets EE; Muto MG; Sun D; Crum CP
    Gynecol Oncol; 2000 Apr; 77(1):171-6. PubMed ID: 10739707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic imbalance and human papillomavirus states in vulvar squamous cell carcinomas.
    Yangling O; Shulang Z; Rongli C; Bo L; Lili C; Xin W
    Eur J Gynaecol Oncol; 2007; 28(6):442-6. PubMed ID: 18179133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
    Huang FY; Kwok YK; Lau ET; Tang MH; Ng TY; Ngan HY
    Cancer Genet Cytogenet; 2005 Feb; 157(1):42-8. PubMed ID: 15676146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of loss of heterozygosity in vulval intraepithelial neoplasia (VIN) is associated with invasive vulval squamous cell carcinoma (VSCC).
    Rosenthal AN; Ryan A; Hopster D; Surentheran T; Jacobs IJ
    Int J Cancer; 2001 Dec; 94(6):896-900. PubMed ID: 11745496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The most common chromosome aberration detected by high-resolution comparative genomic hybridization in vulvar intraepithelial neoplasia is not seen in vulvar squamous cell carcinoma.
    Bryndorf T; Kirchhoff M; Larsen J; Andreasson B; Bjerregaard B; Westh H; Rose H; Lundsteen C
    Cytogenet Genome Res; 2004; 106(1):43-8. PubMed ID: 15218240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.
    Nitecki R; Feltmate CM
    Curr Probl Cancer; 2018 Sep; 42(5):476-485. PubMed ID: 30093165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
    Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
    Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population.
    Hu N; Roth MJ; Polymeropolous M; Tang ZZ; Emmert-Buck MR; Wang QH; Goldstein AM; Feng SS; Dawsey SM; Ding T; Zhuang ZP; Han XY; Ried T; Giffen C; Taylor PR
    Genes Chromosomes Cancer; 2000 Mar; 27(3):217-28. PubMed ID: 10679910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
    Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.
    Yamamoto S; Tsuda H; Suzuki K; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2009 Sep; 455(3):261-70. PubMed ID: 19655165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.